AAAAAA

   
Results: 1-13 |
Results: 13
MANAGEMENT OF THE FIBROID UTERUS (REPRINTED FROM ADVANCES IN OBSTETRICS AND GYNECOLOGY, VOL 3, PG 103-27, 1996)
Authors: BURKMAN RT
Citation: Rt. Burkman, MANAGEMENT OF THE FIBROID UTERUS (REPRINTED FROM ADVANCES IN OBSTETRICS AND GYNECOLOGY, VOL 3, PG 103-27, 1996), Current problems in obstetrics, gynecology and fertility, 21(2), 1998, pp. 31-46
ORAL-CONTRACEPTIVE PRACTICE GUIDELINES
Authors: BURKMAN RT SHULMAN LP
Citation: Rt. Burkman et Lp. Shulman, ORAL-CONTRACEPTIVE PRACTICE GUIDELINES, Contraception, 58(3), 1998, pp. 35-43
ANALYSIS OF 315 ECTOPIC PREGNANCIES TREATED WITH SINGLE-DOSE METHOTREXATE - DISCUSSION
Authors: ZINAMAN M ORY S GERBIE M BURKMAN RT HILL WC WAGNER AM MAURUS JN WESTER RJ",LIPSCOMB
Citation: M. Zinaman et al., ANALYSIS OF 315 ECTOPIC PREGNANCIES TREATED WITH SINGLE-DOSE METHOTREXATE - DISCUSSION, American journal of obstetrics and gynecology, 178(6), 1998, pp. 1356-1358
THE ESTROGEN COMPONENT OF OCS - CARDIOVASCULAR BENEFITS AND RISKS
Authors: BURKMAN RT
Citation: Rt. Burkman, THE ESTROGEN COMPONENT OF OCS - CARDIOVASCULAR BENEFITS AND RISKS, International journal of fertility and women's medicine, 42, 1997, pp. 145-157
THE INTRAUTERINE CONTRACEPTIVE DEVICE - AN ACCEPTABLE ALTERNATIVE TO STERILIZATION IN YOUNG-WOMEN
Authors: BURKMAN RT
Citation: Rt. Burkman, THE INTRAUTERINE CONTRACEPTIVE DEVICE - AN ACCEPTABLE ALTERNATIVE TO STERILIZATION IN YOUNG-WOMEN, American journal of obstetrics and gynecology, 177(4), 1997, pp. 977-978
ORAL-CONTRACEPTIVE USE AND CORONARY AND CARDIOVASCULAR RISK
Authors: BURKMAN RT
Citation: Rt. Burkman, ORAL-CONTRACEPTIVE USE AND CORONARY AND CARDIOVASCULAR RISK, Medicine and science in sports and exercise, 28(1), 1996, pp. 11-12
ORAL-CONTRACEPTIVES - AN UPDATE
Authors: BURKMAN RT
Citation: Rt. Burkman, ORAL-CONTRACEPTIVES - AN UPDATE, Hospital practice, 30(4), 1995, pp. 85
THE ROLE OF ORAL-CONTRACEPTIVES IN THE TREATMENT OF HYPERANDROGENIC DISORDERS
Authors: BURKMAN RT
Citation: Rt. Burkman, THE ROLE OF ORAL-CONTRACEPTIVES IN THE TREATMENT OF HYPERANDROGENIC DISORDERS, The American journal of medicine, 98, 1995, pp. 130-136
A CONTINUOUS QUALITY IMPROVEMENT PROJECT TO IMPROVE THE QUALITY OF CERVICAL PAPANICOLAOU SMEARS
Authors: BURKMAN RT WARD R BALCHANDANI K KINI S
Citation: Rt. Burkman et al., A CONTINUOUS QUALITY IMPROVEMENT PROJECT TO IMPROVE THE QUALITY OF CERVICAL PAPANICOLAOU SMEARS, Obstetrics and gynecology, 84(3), 1994, pp. 470-475
NONCONTRACEPTIVE EFFECTS OF HORMONAL CONTRACEPTIVES - BONE MASS, SEXUALLY-TRANSMITTED DISEASE AND PELVIC INFLAMMATORY DISEASE, CARDIOVASCULAR-DISEASE, MENSTRUAL FUNCTION, AND FUTURE FERTILITY
Authors: BURKMAN RT
Citation: Rt. Burkman, NONCONTRACEPTIVE EFFECTS OF HORMONAL CONTRACEPTIVES - BONE MASS, SEXUALLY-TRANSMITTED DISEASE AND PELVIC INFLAMMATORY DISEASE, CARDIOVASCULAR-DISEASE, MENSTRUAL FUNCTION, AND FUTURE FERTILITY, American journal of obstetrics and gynecology, 170(5), 1994, pp. 1569-1575
PUERPERIUM AND BREAST-FEEDING
Authors: BURKMAN RT
Citation: Rt. Burkman, PUERPERIUM AND BREAST-FEEDING, Current opinion in obstetrics & gynecology, 5(5), 1993, pp. 683-687
CONTRACEPTION AND DYSLIPIDEMIA
Authors: KNOPP RH LAROSA JC BURKMAN RT
Citation: Rh. Knopp et al., CONTRACEPTION AND DYSLIPIDEMIA, American journal of obstetrics and gynecology, 168(6), 1993, pp. 1994-2005
A RANDOMIZED TRIAL OF 3 ORAL-CONTRACEPTIVES - COMPARISON OF BLEEDING PATTERNS BY CONTRACEPTIVE TYPES AND STEROID-LEVELS
Authors: SALEH WA BURKMAN RT ZACUR HA KIMBALL AW KWITEROVICH P BELL WK
Citation: Wa. Saleh et al., A RANDOMIZED TRIAL OF 3 ORAL-CONTRACEPTIVES - COMPARISON OF BLEEDING PATTERNS BY CONTRACEPTIVE TYPES AND STEROID-LEVELS, American journal of obstetrics and gynecology, 168(6), 1993, pp. 1740-1747
Risultati: 1-13 |